To unlock this feature and to subscribe to our weekly evidence emails, please create a FREE orthoEvidence account.

SIGNUP

Already Have an Account?

Loading...
Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
Ace Report Cover

Similar Adverse Events & Complications with Aspirin vs Enoxparin for Hip/Knee Arthroplasty Patients

Share
Reprints
Cite This
About
+ Favorites
Share
Reprints
Cite This
About
+ Favorites
Author Verified
Ace Report Cover
March 2021

Similar Adverse Events & Complications with Aspirin vs Enoxparin for Hip/Knee Arthroplasty Patients

Vol: 10| Issue: 3| Number:11| ISSN#: 2564-2537
Study Type:Therapy
OE Level Evidence:1
Journal Level of Evidence:1

Aspirin versus enoxaparin for the initial prevention of venous thromboembolism following elective arthroplasty of the hip or knee: A systematic review and meta-analysis

Orthop Traumatol Surg Res. 2021 Feb;107(1): 102606.

Contributing Authors:
JE Farey VVG An V Sidhu S Karunaratne IA Harris

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here

Synopsis

Four randomized controlled trials including 1507 adult patients with osteoarthritis (OA) undergoing an elective hip or knee arthroplasty were included in this meta-analysis comparing the use of aspirin to enoxaparin after surgery for thromboprophylaxis. The primary outcomes of interest included incidence of venous thromboembolism (VTE) and mortality, which were evaluated up to 3-months post-surger...

CME Image

Did you know that you’re eligible to earn 0.5 CME credits for reading this report!

LEARN MORE

Join the Conversation

Please Login or Join to leave comments.

Learn about our AI Driven
High Impact Search Feature

High Impact Icon

Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.

Continue